Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0322 Transporter Info
Gene Name	SLC37A1
Transporter Name	Glycerol-3-phosphate permease
Gene ID	54020
UniProt ID	P57057

Post-Translational Modification of This DT
Overview of SLC37A1 Modification Sites with Functional and Structural Information
Sequence	M A R L P A G I R F I I S F S R D Q W Y R A F I F I L T F L L Y A S F H L S R K P I S I V K G E L H K Y C T A W D E A D V R F S S Q N R K S G S A A P H Q L P D N E T D C G W A P F D K N N Y Q Q L L G A L D Y S F L C A Y A V G M Y L S G I I G E R L P I R Y Y L T F G M L A S G A F T A L F G L G Y F Y N I H S F G F Y V V T Q V I N G L V Q T T G W P S V V T C L G N W F G K G R R G L I M G V W N S H T S V G N I L G S L I A G Y W V S T C W G L S F V V P G A I V A A M G I V C F L F L I E H P N D V R C S S T L V T H S K G Y E N G T N R L R L Q K Q I L K S E K N K P L D P E M Q C L L L S D G K G S I H P N H V V I L P G D G G S G T A A I S F T G A L K I P G V I E F S L C L L F A K L V S Y T F L F W L P L Y I T N V D H L D A K K A G E L S T L F D V G G I F G G I L A G V I S D R L E K R A S T C G L M L L L A A P T L Y I F S T V S K M G L E A T I A M L L L S G A L V S G P Y T L I T T A V S A D L G T H K S L K G N A H A L S T V T A I I D G T G S V G A A L G P L L A G L L S P S G W S N V F Y M L M F A D A C A L L F L I R L I H K E L S C P G S A T G D Q V P F K E Q
PTM type	X-Malonylation X-Phosphorylation X-Ubiquitination X: Amino Acid

Malonylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC37A1			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	40
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at SLC37A1 Lysine 40 has the potential to affect its expression or activity.
Phosphorylation
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC37A1			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	43
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC37A1 Serine 43 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC37A1			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	293
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC37A1 Serine 293 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC37A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	333
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC37A1 Serine 333 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC37A1			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	453
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC37A1 Serine 453 has the potential to affect its expression or activity.
Ubiquitination
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC37A1			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	51
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC37A1 Lysine 51 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC37A1			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC37A1 Lysine 272 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC37A1			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC37A1 Lysine 281 has the potential to affect its expression or activity.

References
1	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
2	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3	Protein kinase C-alpha interaction with F0F1-ATPase promotes F0F1-ATPase activity and reduces energy deficits in injured renal cells. J Biol Chem. 2015 Mar 13;290(11):7054-66.
4	Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep. 2014 Sep 11;8(5):1583-94.
5	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence